Jackie C. Bloomer

Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie”

Zoe Riches, Emma L. Stanley, Jackie C. Bloomer et al. · Drug Metabolism and Disposition · 2009 · 355 citations · Full text

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2

Josie A. Blackie, Jackie C. Bloomer, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 129 citations · Full text

Lipoprotein-associated Phospholipase A2, Biochemistry, Potent Inhibitor +8

Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds

Melanie Z. Sakatis, Melinda J. Reese, Andrew W. Harrell et al. · Chemical Research in Toxicology · 2012 · 120 citations

System Pharmacology, Vitro Bioactivation Data, Pharmacodynamic Modeling +21

The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects

Bruce E. Miller, Sunil Mistry, Kevin Smart et al. · BMC Pharmacology and Toxicology · 2015 · 63 citations · Full text

Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development

Carole Shardlow, Grant T. Generaux, Aarti Patel et al. · Drug Metabolism and Disposition · 2013 · 40 citations